- Report
- August 2023
- 51 Pages
Switzerland
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Argentina
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Brazil
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Israel
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Colombia
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
India
From €555EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
South Africa
From €555EUR$600USD£463GBP
- Report
- July 2023
- 100 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- June 2023
- 62 Pages
Global
From €1804EUR$1,950USD£1,505GBP
- Report
- December 2021
- 353 Pages
Global
From €5087EUR$5,500USD£4,245GBP
- Report
- August 2025
- 150 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- November 2025
- 107 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- November 2024
- 120 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- May 2024
- 95 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- February 2024
- 91 Pages
Global
From €3500EUR$4,054USD£3,023GBP
- Report
- February 2022
- 87 Pages
Global
From €3200EUR$3,706USD£2,764GBP
- Report
- January 2025
- 132 Pages
Global
From €879EUR$950USD£733GBP
- Report
- January 2025
- 132 Pages
Global
From €879EUR$950USD£733GBP
- Report
- January 2025
- 132 Pages
Global
From €879EUR$950USD£733GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more